ADAR and other genes in the 1q21 amplicon are linked to tumour growth and/or treatment sensitivity due to the elevation of the expressed genes, which are brought on by the higher gene dosage in MM cells with 1q21+.156. This evidence concerns the gene ADAR and Miyoshi myopathy.